Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice

被引:86
作者
Cobble, Michael [1 ]
Bale, Bradley [2 ]
机构
[1] Canyons Med Ctr, Sandy, UT 84094 USA
[2] Grace Clin, Lubbock, TX USA
关键词
atherosclerosis; cardiovascular disease; carotid intima-media thickness; CIMT; heart disease; EXTENDED-RELEASE NIACIN; B-MODE ULTRASOUND; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY INTIMA; RISK-FACTORS; PROGRESSION; REDUCTION; ASSOCIATION;
D O I
10.3810/pgm.2010.01.2091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart disease is the primary cause of death in the United States. Fortunately, intervention measures can reduce the risk of cardiovascular disease (CVD) after a patient has been accurately assessed. Atherosclerotic disease, one of the driving forces behind CVD, is not always detected by traditional risk assessment. Carotid intima-media thickness (CIMT), as measured by B-mode ultrasound, is a surrogate marker for atherosclerosis and can be used to detect an accelerated disease process and subclinical disease. Advantages of CIMT are that it is noninvasive, relatively inexpensive, and can be repeatedly performed with no adverse effects on the patient. Carotid intima-media thickness is associated with CVD and is an independent predictor of stroke and myocardial infarction. Therefore, CIMT is valuable for clarifying CVD risk, particularly for patients with intermediate risk by conventional risk assessment. Screening for subclinical disease even in low-risk patients may have benefit, especially for those with a family history of premature CVD or those with any of the National Cholesterol Education Pro,,ram risk factors. The detection of subclinical atherosclerosis allows the physician to implement prevention efforts prior to a devastating CVD event and to investigate possible reasons for increased arterial thickening, Such as in occult underlying insulin-resistant condition or residual lipid risk markers. Treatment with several types of drugs has been demonstrated to halt the progression or even reduce CIMT. Carotid intima-media thickness is currently limited by the lack of standardized protocols that may affect reproducibility from measure to measure. Efforts to draft a standardized protocol are underway by the Society of Atherosclerosis Imaging and Prevention that will address this issue. Carotid intima-media thickness provides a valuable tool for physicians to clarify the CVD risk of their patients. Practical implications of CIMT for everyday clinical practice are addressed.
引用
收藏
页码:10 / 18
页数:9
相关论文
共 54 条
  • [1] Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings
    Amato, Mauro
    Montorsi, Piero
    Ravani, Alessio
    Oldani, Elisa
    Galli, Stefano
    Ravagnani, Paolo M.
    Tremoli, Elena
    Baldassarre, Damiano
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (17) : 2094 - 2101
  • [2] Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives
    Anderssen, SA
    Hjelstuen, AK
    Hjermann, I
    Bjerkan, K
    Holme, I
    [J]. ATHEROSCLEROSIS, 2005, 178 (02) : 387 - 397
  • [3] Endpoints in clinical trials: does evidence only originate from 'hard' or mortality endpoints?
    Asmar, Roland
    Hosseini, Hassan
    [J]. JOURNAL OF HYPERTENSION, 2009, 27 : S45 - S50
  • [4] Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study
    Baldassarre, D
    Veglia, F
    Gobbi, C
    Gallus, G
    Ventura, A
    Crepaldi, G
    Fisicaro, M
    Rimondi, S
    Ricci, G
    Mancini, M
    Bond, MG
    Collatina, S
    Sirtori, CR
    [J]. ATHEROSCLEROSIS, 2000, 151 (02) : 575 - 583
  • [5] BENEFICIAL-EFFECTS OF COLESTIPOL-NIACIN THERAPY ON THE COMMON CAROTID-ARTERY - 2-YEAR AND 4-YEAR REDUCTION OF INTIMA-MEDIA THICKNESS MEASURED BY ULTRASOUND
    BLANKENHORN, DH
    SELZER, RH
    CRAWFORD, DW
    BARTH, JD
    LIU, CR
    LIU, CH
    MACK, WJ
    ALAUPOVIC, P
    [J]. CIRCULATION, 1993, 88 (01) : 20 - 28
  • [6] Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?
    Bots, Michiel L.
    Baldassarre, Damiano
    Simon, Alain
    de Groot, Eric
    O'Leary, Daniel H.
    Riley, Ward
    Kastelein, John J.
    Grobbee, Diederick E.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (04) : 398 - 406
  • [7] Carotid intima-media thickness measurements in intervention studies - Design options, progression rates, and sample size considerations: A point of view
    Bots, ML
    Evans, GW
    Riley, WA
    Grobbee, DE
    [J]. STROKE, 2003, 34 (12) : 2985 - 2994
  • [8] Current concepts - Computed tomography - An increasing source of radiation exposure
    Brenner, David J.
    Hall, Eric J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) : 2277 - 2284
  • [9] Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497